Literature DB >> 16079100

Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells.

Cecilia Götherström1, Anne West, Johan Liden, Mehmet Uzunel, Riitta Lahesmaa, Katarina Le Blanc.   

Abstract

BACKGROUND AND OBJECTIVES: Mesenchymal stem cells (MSC) are progenitor cells that are capable of differentiating into mesenchymal tissues. Fetal and adult MSC have similar morphology but differ in proliferative, differentiating and immunosuppressive properties. Further exploring their differences could help in choosing the right source for cellular therapy. DESIGN AND METHODS: The gene expression profiles of undifferentiated MSC derived from first trimester fetal liver and adult bone marrow were compared by serial analysis of gene expression, and validated by either reverse transcription polymerase chain reaction or immunoblotting of selected genes. The immunophenotype was compared by flow cytometry and cell ELISA.
RESULTS: Seventy genes were differentially induced two-fold or more in fetal MSC compared to adult MSC. These involved transcripts regulating germ plasm and limb patterning, brain and early muscle development. Transcripts implicated in cell cycle promotion, chromatin regulation and DNA repair were also more abundant in fetal MSC. Ninety-seven genes were decreased two-fold or more in fetal MSC, including transcripts involved in smooth muscle and keratinocyte differentiation and transcripts for immunological genes. Although phenotypically largely similar, fetal MSC had a higher expression of ICAM1 and contained intracellular deposits of HLA-G while expression of HLA class I and II molecules and VCAM1 was increased in adult MSC. INTERPRETATION AND
CONCLUSIONS: This study reports the first extensive investigation of the differences in gene expression profiles between fetal and adult MSC. The results suggest that fetal MSC have higher proliferative capacity and are less lineage committed than adult MSC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079100

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  43 in total

1.  Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment.

Authors:  Günter Lepperdinger; Regina Brunauer; Robert Gassner; Angelika Jamnig; Frank Kloss; Gerhard Thomas Laschober
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

Review 2.  Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.

Authors:  Rita Anzalone; Melania Lo Iacono; Tiziana Loria; Antonino Di Stefano; Pantaleo Giannuzzi; Felicia Farina; Giampiero La Rocca
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

3.  Human mesenchymal stem cells derived from limb bud can differentiate into all three embryonic germ layers lineages.

Authors:  Fei Jiao; Juan Wang; Zhao-Lun Dong; Min-Juan Wu; Ting-Bao Zhao; Dan-Dan Li; Xin Wang
Journal:  Cell Reprogram       Date:  2012-07-09       Impact factor: 1.987

Review 4.  Stem cells in the umbilical cord.

Authors:  Mark L Weiss; Deryl L Troyer
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

5.  Comparative immune-phenotypic and functional characteristics of mesenchymal stromal cells from definitive and transitory hematopoietic organs.

Authors:  M N Kozhevnikova; A S Mikaelyan; V I Starostin
Journal:  Dokl Biol Sci       Date:  2008 Sep-Oct

6.  Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues.

Authors:  Markus Thomas Rojewski; Barbara Maria Weber; Hubert Schrezenmeier
Journal:  Transfus Med Hemother       Date:  2008-05-16       Impact factor: 3.747

7.  Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming.

Authors:  Mehdi Najar; Gordana Raicevic; Hussein Fayyad-Kazan; Hussein Fayyad Kazan; Cécile De Bruyn; Dominique Bron; Michel Toungouz; Laurence Lagneaux
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

Review 8.  The bright and the dark sides of DNA repair in stem cells.

Authors:  Guido Frosina
Journal:  J Biomed Biotechnol       Date:  2010-04-08

9.  Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Authors:  S Jyothi Prasanna; Divya Gopalakrishnan; Shilpa Rani Shankar; Anoop Babu Vasandan
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

10.  Derivation of mesenchymal stromal cells from canine induced pluripotent stem cells by inhibition of the TGFβ/activin signaling pathway.

Authors:  Deanne J Whitworth; Jessica E Frith; Thomas J R Frith; Dmitry A Ovchinnikov; Justin J Cooper-White; Ernst J Wolvetang
Journal:  Stem Cells Dev       Date:  2014-12-15       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.